Judge Chhabria: CDC Vaccine Schedule Lawsuit Advances

• A federal judge allowed states to proceed with a lawsuit challenging recent changes to the CDC's childhood immunization schedule.
• Judge Vince Chhabria ruled that states have standing to sue because the changes could increase their healthcare costs and administrative burdens.
• The CDC recently removed universally recommended status from seven childhood vaccines and dropped the universal hepatitis B birth dose recommendation.
• These federal policy shifts followed recommendations from an advisory committee appointed by HHS Secretary Robert F. Kennedy Jr.
• Claims related to the appointment of advisory committee members and harms from states tying their laws directly to committee recommendations were dismissed by the court.

By affirming that states have standing to challenge federal changes to vaccine recommendations, the court has established a precedent that could lead to increased litigation against federal health agencies.

A federal judge recently advanced a significant legal challenge against the Trump administration concerning modifications to the national childhood immunization schedule. The U.S. Centers for Disease Control and Prevention (CDC) had recently removed the universally recommended status from seven specific childhood vaccines, a move that prompted a multi-state lawsuit. This action by the CDC followed recommendations from an advisory committee whose members were newly appointed by Health and Human Services Secretary Robert F. Kennedy Jr.

In December, the CDC specifically ceased recommending a universal birth dose for the hepatitis B vaccine, despite its reported efficacy of up to 90% in preventing perinatal infection when administered within 24 hours of birth. Subsequently, on January 5, acting on further recommendations from Secretary Kennedy, the CDC downgraded vaccines protecting against rotavirus, meningococcal disease, hepatitis A, hepatitis B, influenza, Covid-19, and respiratory syncytial virus (RSV) from the standard recommended childhood schedule. These vaccines are now designated for high-risk patients or for use in situations involving "shared clinical decision-making."

California Attorney General Rob Bonta and Arizona Attorney General Kris Mayes initiated legal action against the administration in February, joined by 13 other Democratic-led states and Pennsylvania Governor Josh Shapiro. Their lawsuit contends that these changes have introduced widespread confusion, eroded public trust in vaccinations, and potentially jeopardized millions of lives.

In a pivotal decision issued on a Tuesday, U.S. District Judge Vince Chhabria partially rejected the government's motion to dismiss the lawsuit, allowing key claims to proceed. The judge, an appointee of Barack Obama, determined that the plaintiff states possess the necessary standing to challenge the CDC's extensive revisions to the childhood immunization schedule. Specifically, the states can challenge the elimination of the universal birth dose recommendation for the hepatitis B vaccine and the broader alterations to the schedule.

Judge Chhabria's ruling highlighted that the states had plausibly demonstrated that these federal decisions would likely escalate the operational costs of state healthcare programs and impose new administrative burdens related to adjusting state laws. The five-page order dismissed the government's argument that the states' causal chain was too speculative, instead finding that the states had clearly articulated how patients and medical professionals would react to the revised vaccine recommendations. The court also dismissed claims related to Robert F. Kennedy Jr.'s replacement of members on a vaccine advisory committee, stating that any harms from states tying their laws directly to the committee's recommendations were "self-inflicted."

The ruling by Judge Chhabria confirmed that states face tangible financial and administrative injuries due to the CDC's changes. He rejected the government's assertion that states are entirely free to establish their own vaccine policies, emphasizing that state laws and regulations must operate within the framework of a baseline federal legal regime. The judge underscored the CDC's central role in disease control and in setting minimum standards for vaccine coverage, concluding that the administrative costs incurred by states to address gaps created by the CDC's alleged failure to provide an adequate vaccine schedule constitute cognizable injuries.

This ruling by Judge Chhabria in the CDC vaccine schedule lawsuit carries significant implications for public health policy and the balance of power between federal and state authorities. The court found it plausible that downgrading a vaccine from "universally recommended" to a "shared clinical decision-making" status would predictably lead to a decrease in vaccine uptake across the population. This, in turn, could create a substantial risk of an increase in vaccine-preventable disease outbreaks, directly impacting public health outcomes.

The decision underscores the critical role of federal recommendations in shaping state-level healthcare policies and expenditures. By affirming that states have standing to challenge federal changes to vaccine recommendations, the court has established a precedent that could lead to increased litigation against federal health agencies. This allows states to hold federal bodies accountable for decisions that could impose significant financial and administrative burdens, such as the need to adjust state laws and programs in response to altered federal guidelines.

Ultimately, this legal development highlights the intricate relationship between federal public health guidance and state autonomy. It suggests that federal agencies like the CDC must consider the downstream financial and administrative impacts on states when making sweeping changes to public health recommendations, particularly concerning critical areas like childhood immunization. The ability of states to challenge these decisions in court ensures a mechanism for addressing potential disruptions to state healthcare systems and public health initiatives.

This ruling confirms that states have standing to challenge federal changes to vaccine recommendations, establishing a precedent for litigation against federal health agencies over public health policy. Lawyers advising state governments or healthcare providers should note the potential for increased legal challenges and regulatory uncertainty regarding vaccine schedules and related state laws.

Source: Original reporting via Associated Press